Articles & guides — page 3
127 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.
127 articles
What is tesamorelin?
Tesamorelin explained: a stabilised GHRH analog and — unlike most peptides in its family — an FDA-approved medicine (Egrifta), with the HIV lipodystrophy trials that got it there.
Approved medicineCompound overviews6 minWhat is retatrutide?
Retatrutide explained plainly: the investigational "triple G" agonist that hits three hormone receptors — GIP, GLP-1, and glucagon — and what its phase-2 trials showed (~24% weight loss).
Human clinical dataCompound overviews4 minWhat is SLU-PP-332?
SLU-PP-332 explained with the science: a synthetic pan-ERR agonist studied as an "exercise mimetic" — what it did in mice for metabolism and fitness, and why there is no human data.
PreclinicalCompound overviews4 minWhat is MOTS-c?
MOTS-c explained with the science: a mitochondrial-derived peptide studied as an exercise mimetic for metabolism and aging, and why almost all the strong evidence is from mice and cells.
PreclinicalTracking & protocols7 minSLU-PP-332 doses: what 133 people actually report
First-party data: 216 structured SLU-PP-332 reports from 133 people. The community splits almost exactly in half over whether this is a microgram or a milligram compound.
PreclinicalTracking & protocols6 minMOTS-c: what your body makes, what mice did, and what 202 people actually report
First-party data on MOTS-c: 294 structured reports from 202 people describing their own use, set against the human evidence (endogenous levels, measured) and the mouse evidence (injected, per kilogram). No human trial of injected MOTS-c exists.
PreclinicalTracking & protocols7 minBPC-157 doses: what 182 people actually report
First-party data: 244 structured BPC-157 reports from 182 people — the dose distribution by route, the milligram/microgram collision hiding inside it, stacks, and honest evidence context.
PreclinicalUsing Zyra Track4 minBest peptide tracker apps, compared honestly
Six peptide tracker apps compared on protocols, inventory, levels curves, labs, and cited sources — including free options. We build Zyra Track; every claim is checkable.
Concept / methodCompound overviews5 minWhat is ARA-290 (cibinetide)?
ARA-290 (cibinetide) explained: a non-hematopoietic EPO-derived peptide that targets the innate repair receptor — with the real human trials in small-fibre neuropathy.
Human clinical dataCompound overviews4 minWhat is Adipotide?
Adipotide (FTPP) explained honestly: a peptide that kills the blood supply of white fat, the dramatic obese-monkey results, the kidney catch, and why it never reached people.
PreclinicalCompound overviews4 minWhat is AHK-Cu?
AHK-Cu explained: the copper tripeptide studied for hair — how it stimulates dermal papilla cells, how it differs from GHK-Cu, and the honest evidence limits.
PreclinicalCompound overviews4 minWhat is MGF (mechano growth factor)?
MGF (mechano growth factor) explained honestly: the IGF-1 splice variant your muscles make after training, what the injectable peptide is, and why it has no human trials.
PreclinicalZyra Track is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.